Wright Intros CLAW II System

International orthopedic devices company Wright Medical (WMGI) has commenced full launch of its CLAW II polyaxial compression plating system for foot and ankle surgeries. The Tennessee-based company said that the new plating system will be available in the U.S. through its foot and ankle sales force. Outside the U.S., it will be marketed in select nations through the company’s direct sales team as well as distribution partners.

The CLAW II system, which features Wright Medical’s ORTHOLOC 3DSi polyaxial locking screw technology, integrates the stability and adjustable compression features of the company’s CLAW plating system with better surgical flexibility enabled by new shape configurations and polyaxial screw positioning.

The ORTHOLOC technology offers surgeons with greater flexibility in placing a locking screw and enables them to solidly lock the screw to the plate, thereby providing enhanced stability.

The CLAW II system, which is built upon the success of Wright Medical’s CHARLOTTE CLAW plating system, further reinforces the company’s foot and ankle product franchise. It has been fine tuned to enable surgeons to choose the appropriate implants while performing fusions in the foot and ankle.

Wright Medical is a global orthopedic devices company specializing in the development and marketing of reconstructive joint devices and bio-orthopedic materials. It is a leader in the U.S. and German markets for foot and ankle surgical products. The company retains its strength in the niche extremities segment.

We feel future revenue growth will be supported by new product (including internally developed and those from acquisitions) launches. Moreover, new deals in extremities, Wright Medical’s fastest growing segment, are expected to bolster growth in this business. Within extremities, foot and ankle products are expected to be a major growth driver.

However, our views are moderated by lingering compliance issues and intense competition from larger orthopedic players. Wright Medical competes with much larger players such as Zimmer Holdings (ZMH), Stryker (SYK), Johnson & Johnson’s (JNJ) De Puy and Smith & Nephew (SNN).

Moreover, the company remains exposed to pricing/procedure volume headwinds. Costs associated with restructuring will also continue to be a drag on the company’s bottom line. We are currently Neutral on Wright Medical. The stock curently retains a short-term Zacks #4 Rank (Sell).

About the author

Josh Sandberg

Josh Sandberg has been an executive search consultant focused exclusively on orthopedic and spine start-ups since 2004. He has had a tremendous impact in helping his clients avoid costly hiring mistakes by his deep industry knowledge and network. In 2010, Josh co-founded Ortho Spine Companies, which is the parent company of Ortho Spine Distributors (OSD), Surg.io and Ortho Sales Partners (OSP). OSD a searchable database that helps ease the frustration of finding orthopedic distributors throughout the country. Surg.io is the ultimate distributor toolkit that offers distributors the tools necessary to build the foundation of a scalable and highly functioning sales organization. OSP is an end-to-end solution that helps companies approach the Global Market in a cost efficient way. Our team has hundreds of years of experience and can help you navigate the many challenges present in bringing new technologies to the market.

Add Comment

Click here to post a comment

Your email address will not be published. Required fields are marked *

Download our App

Developer: Fifty Pixels Ltd
Price: Free
Developer: Fifty Pixels Ltd
Price: Free



With Conference Season Ending, Which Spine Conference Are You Looking Forward to the Most in 2017?

View Results

Loading ... Loading ...